On (b)(6) 2022, neotract was made aware of an adverse event from the clear study.On 17 may 2022, a patient underwent a successful prostatic urethral lift (pul) procedure and was catheterized without a void trial.It was reported that the patient had two unsuccessful void trials and presented to urgent care on (b)(6) 2022, where he was diagnosed with a uti and prescribed an oral antibiotic.On (b)(6) 2022 he presented to the er and was admitted and prescribed iv and oral antibiotics.His catheter was removed and he was discharged from the hospital on (b)(6) 2022 with oral antibiotics.
|